PRGO N logo

Perrigo BMV:PRGO N Stock Report

Last Price

Mex$557.52

Market Cap

Mex$68.8b

7D

0%

1Y

n/a

Updated

30 Jan, 2025

Data

Company Financials +

Perrigo Company plc

BMV:PRGO N Stock Report

Market Cap: Mex$68.8b

PRGO N Stock Overview

Provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. More details

PRGO N fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health3/6
Dividends3/6

Rewards

Trading at 60.2% below our estimate of its fair value

Earnings are forecast to grow 64.35% per year

Risk Analysis

Shares are highly illiquid

Dividend of 4.48% is not well covered by earnings or free cash flows

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

Perrigo Company plc Competitors

Genomma Lab Internacional. de

BMV:LAB B

Mex$25.4b

Santen Pharmaceutical

TSE:4536

JP¥530.8b

Asymchem Laboratories (Tianjin)

SZSE:002821

CN¥25.7b

Laboratorios Farmaceuticos Rovi

BME:ROVI

€3.3b

Price History & Performance

Summary of share price highs, lows and changes for Perrigo
Historical stock prices
Current Share PriceUS$557.52
52 Week HighUS$557.52
52 Week LowUS$557.52
Beta0.53
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change-49.52%
Change since IPO-50.43%

Recent News & Updates

Recent updates

Shareholder Returns

PRGO NMX PharmaceuticalsMX Market
7D0%0.8%0.8%
1Yn/a-19.2%-12.3%

Return vs Industry: Insufficient data to determine how PRGO N performed against the MX Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how PRGO N performed against the MX Market.

Price Volatility

Is PRGO N's price volatile compared to industry and market?
PRGO N volatility
PRGO N Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement4.0%
10% most volatile stocks in MX Market6.8%
10% least volatile stocks in MX Market2.7%

Stable Share Price: PRGO N's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine PRGO N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
18879,140Patrick Lockwood-Taylorwww.perrigo.com

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Perrigo Company plc Fundamentals Summary

How do Perrigo's earnings and revenue compare to its market cap?
PRGO N fundamental statistics
Market capMex$68.76b
Earnings (TTM)-Mex$3.00b
Revenue (TTM)Mex$89.73b

0.8x

P/S Ratio

-22.9x

P/E Ratio

Is PRGO N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRGO N income statement (TTM)
RevenueUS$4.39b
Cost of RevenueUS$2.81b
Gross ProfitUS$1.58b
Other ExpensesUS$1.73b
Earnings-US$146.90m

Last Reported Earnings

Sep 28, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.08
Gross Margin36.07%
Net Profit Margin-3.34%
Debt/Equity Ratio104.8%

How did PRGO N perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

-103%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 09:28
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/28
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Perrigo Company plc is covered by 39 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Ishan MajumdarBaptista Research
Douglas TsaoBarclays